Search Results 41-50 of 16656 for Neurofibromatosis

  1. In the Loop: Sampson returns home to Liberia - Mayo Clinic News Network

    The growths were caused by neurofibromatosis, a condition Sampson was born with. It's a condition that — as we reported when Sampson first came to Rochester ...

  2. Schwannomatosis - Care at Mayo Clinic

    The Neurofibromatosis Clinic also has genetic counselors who can help you make decisions that are appropriate for you and your family. Counselors can help ...

  3. Radhika Dhamija, M.B.B.S. - Mayo Clinic Faculty Profiles

    She studies and reports new findings in rare genetic disorders and neurocutaneous disorders with focus on neurofibromatosis and schwannomatosis. Dr. Dhamija ...

  4. Neuroendocrine tumors - Symptoms and causes - Mayo Clinic

    Multiple endocrine neoplasia, type 1 (MEN 1); Multiple endocrine neoplasia, type 2 (MEN 2); Von Hippel-Lindau disease; Tuberous sclerosis; Neurofibromatosis ...

  5. Pediatric brain tumors - Symptoms and causes - Mayo Clinic

    Neurofibromatosis 2. Tuberous sclerosis. Gorlin syndrome. Turcot syndrome. Cowden syndrome. Tests of your child's DNA can show whether these syndromes are ...

  6. Expert guidance for vestibular schwannomas' complex treatment decisions - Mayo Clinic

    Mayo Clinic's Neurofibromatosis Type 2 Clinic provides expert, multidisciplinary care for teenagers and adults with this tumor-predisposing genetic disorder.

  7. Rhabdomyosarcoma - Symptoms and causes - Mayo Clinic

    These include neurofibromatosis 1, Noonan syndrome, Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome and Costello syndrome. There is no way to prevent ...

  8. Selumetinib (Oral Route) Description and Brand Names - Mayo Clinic

    Selumetinib is used to treat neurofibromatosis type 1 (NF1) in children 2 years of age and older who have plexiform neurofibromas that cannot be removed by ...

  9. A Study of Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumors that are Recurrent or Cannot Be Removed by Surgery - Mayo Clinic

    Pathologically confirmed MPNST, with or without underlying diagnosis of neurofibromatosis type 1 (diagnostic criteria for neurofibromatosis type 1) ...

  10. Clinical Trials - Mayo Clinic Research

    Title: MEK-NF-201, A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)- ...